choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Carvedilol

Carvedilol Newsletter
  • Dr Reddy's Laboratories, Zydus Pharma recall products in US market 29 Aug 2021 10:45 GMT

    drug makers Dr Reddy's Laboratories and Zydus Pharma are … by the US Food and Drug Administration (USFDA) said. The … Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets … in the bottle." Carvedilol tablets are used to treat …

  • Dr Reddy's, Zydus Pharma recall products in US market 29 Aug 2021 10:30 GMT

    drug makers Dr Reddy's Laboratories and Zydus Pharma are … by the US Food and Drug Administration (USFDA) said. The … Zydus Pharmaceuticals (USA) Inc, is recalling  2,880 bottles of Carvedilol … in the bottle." Carvedilol tablets are used to treat …

  • GlaxoSmithKline LLC v. Teva Pharmaceuticals USA (Fed. Cir. 2021) 13 Aug 2021 05:49 GMT

    … as therapeutically equivalent to other pharmaceutically equivalent products").  Thereafter, … the incentives patents provide for pharmaceutical innovation and the public… generic carvedilol from coming to market altogether—even though the drug itself …

  • What You Don't Know About Beta-Blockers and Hemodialysis 19 Mar 2021 06:29 GMT

    … , my go-to beta-blocker for dialysis patients was carvedilol. It has the … same investigators compared highly dialyzable beta-blockers (atenolol, acebutolol, metoprolol, and bisoprolol … carvedilol. The moral for me is that the dialyzability of a beta-blocker

  • Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript 10 May 2021 23:57 GMT

    … average are usually initiated with pharmacotherapy around three months post diagnosis … Coreg CR, which is Carvedilol, its a beta-blocker commercialized by another product … , and obviously that includes the drug-drug interaction data that we provided …

  • Carvedilol could have unique traits among beta blockers 17 Jul 2020 23:34 GMT

    … eventual failure. Conventionally, beta-blockers aiming the beta-adrenergic receptors have … beta-blocker carvedilol generated a better survival advantage as compared to another drug … , metoprolol tartrate. Carvedilol is said to aim both the beta-

  • GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2020) 09 Oct 2020 07:49 GMT

    … between branded innovator and generic drug makers sanctioned under the Hatch … as therapeutically equivalent to other pharmaceutically equivalent products").  Thereafter, … ;s label before prescribing generic carvedilol.  Rather than suggest inducement, …

  • Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine 06 Mar 2019 13:00 GMT

    … of conventional, HFrEF approved beta-blockers, primarily carvedilol and metoprolol (Fiuzat et … a precision medicine approach to drug development. ARCA’s lead … ), is an investigational, pharmacologically unique beta-blocker and mild vasodilator being …

  • Cancer patients who take beta-blocker along with breast cancer drug have less heart damage 05 Dec 2018 20:41 GMT

    … who take a heart drug at the same time … effect of the breast cancer drug trastuzumab and may force … that patients who take the beta-blocker carvedilol together with trastuzumab have … trastuzumab with, or without, carvedilol. Impaired function of the heart …

  • Your Good Health: Woman allergic to drug, told to take it anyway 19 Feb 2020 12:36 GMT

    … am very sensitive to drugs, and have reacted to … not unheard of. Some beta blockers are similar to propranolol … well, but others, especially carvedilol, are quite unrelated chemically … inadequate sterilization. Finally, injection drug use — even if only …

Satisfied with the content?

Continue to create your account.